Literature DB >> 11675133

Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis.

S Takeo1, H Arai, N Kusano, T Harada, T Furuya, S Kawauchi, A Oga, T Hirano, T Yoshida, K Okita, K Sasaki.   

Abstract

To identify amplified oncogenes involved in hepatocellular carcinomas (HCC), we applied a genomic DNA microarray spotted with 57 oncogenes to 20 HCCs. Aberrations in DNA copy number also were analyzed by comparative genomic hybridization (CGH) using an aliquot of DNA samples. In 5 of 20 HCCs, only 6 oncogenes (CCND1, FGF3/FGF4, SAS/CDK4, TERC, MET, and MYC) were amplified, whereas in the remaining 15 tumors no oncogenes were amplified. A comparison of DNA microarray and conventional CGH analyses showed that, although 5 of 6 amplified oncogenes shown by microarray were located in chromosomal regions shown by CGH to have increased DNA copy numbers, not all genes located in such chromosomal regions were affected. One of the amplified oncogenes (SAS/CDK4) was found in a chromosomal region that was undetected by CGH. We, therefore, conclude that amplification of the oncogenes examined in this series is not directly implicated in hepatocellular carcinogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11675133     DOI: 10.1016/s0165-4608(01)00479-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  19 in total

Review 1.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

2.  Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.

Authors:  James M Rae; Susan J Ramus; Mark Waltham; Jane E Armes; Ian G Campbell; Robert Clarke; Robert J Barndt; Michael D Johnson; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Jump-starting cancer gene discovery.

Authors:  Anthony Uren; Anton Berns
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

Review 4.  Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age.

Authors:  Koji Miyahara; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

Authors:  Yu-Yun Shao; Chih-Hung Hsu; Ann-Lii Cheng
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

6.  Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.

Authors:  Paola Scaruffi; Stefano Parodi; Katia Mazzocco; Raffaella Defferrari; Vincenzo Fontana; Stefano Bonassi; Gian Paolo Tonini
Journal:  Mol Diagn       Date:  2004

7.  Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.

Authors:  Yukiko Nakahara; Tetsuya Shiraishi; Hiroaki Okamoto; Toshihiro Mineta; Tsuyoshi Oishi; Kohsuke Sasaki; Kazuo Tabuchi
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

8.  Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells.

Authors:  Samil Jung; Soonduck Lee; Jayhee Lee; Chengping Li; Ji-Yeon Ohk; Hyeon-Kyung Jeong; Seungkyu Lee; Sangwoo Kim; Yunyeong Choi; Sunghak Kim; Heungwoo Lee; Myeong-Sok Lee
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

Review 9.  Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

Authors:  Yutaka Midorikawa; Masatoshi Makuuchi; Wei Tang; Hiroyuki Aburatani
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

Authors:  Elke Tatjana Aristizabal Prada; Gerald Spöttl; Julian Maurer; Michael Lauseker; Eva Jolanthe Koziolek; Jörg Schrader; Ashley Grossman; Karel Pacak; Felix Beuschlein; Christoph Joseph Auernhammer; Svenja Nölting
Journal:  Endocr Relat Cancer       Date:  2018-06-12       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.